GlobalData on MSN5d
FDA shares new draft guidance for accelerated approvalThe new FDA guidance outlines how surrogate or intermediate clinical endpoints can support accelerated approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback